コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ptive field was in the intact muscles of the low back.
3 ered were: classic SMS (n = 5, involving the low back and lower extremities), variant SMS (n = 2, lim
4 utcome measures included lifetime history of low back and neck pain (using a range of increasingly st
5 llion (UI, $82.7 billion-$92.9 billion), and low back and neck pain accounted for the third-highest a
6 ing on diabetes, ischemic heart disease, and low back and neck pain accounting for the highest amount
9 current US national prevalence estimates of low back and neck pain exist and few studies have invest
10 aemic heart disease, chronic kidney disease, low back and neck pain, and depressive disorders; the la
11 s have investigated the associations between low back and neck pain, psychological factors, and healt
13 of a multidimensional approach to examining low back and neck problems and suggests the need for fur
15 se capacity (-2.0 +/- 2.1 ml/kg per minute), low-back and hamstring flexibility (-4.7 +/- 1.6 cm), an
24 5.5 years of follow-up, 360 workers reported low back injuries, for a rate of 21.2 injuries per 1000
25 ucational program to prevent work-associated low back injury found no long-term benefits associated w
26 d an educational program designed to prevent low back injury in a randomized, controlled trial involv
27 the hopes of preventing costly and disabling low back injury in employees is becoming common in the w
29 education program did not reduce the rate of low back injury, the median cost per injury, the time of
33 am (SMP) on primary care patients with acute low back pain (ALBP) from low income, inner city neighbo
36 ga is effective for mild to moderate chronic low back pain (cLBP), but its comparative effectiveness
38 the afternoon in 47 subjects without current low back pain (IVDs = 230; age range, 20-71 years) after
48 nal treatments for participants with chronic low back pain (Mint study) were conducted in 16 multidis
49 asone recipients demonstrated improvement in low back pain (P = .04, Fisher exact test), whereas 55%
50 betamethasone recipients had improvement in low back pain (P = .26), whereas 49% of triamcinolone re
51 betamethasone recipients had improvement in low back pain (P = .38), whereas 52% of triamcinolone re
54 iagnostic tests in patients with nonspecific low back pain (strong recommendation, moderate-quality e
55 the preceding therapies for acute or chronic low back pain (with or without leg pain) that reported p
59 verity were divided according to symptoms of low back pain alone and symptoms of low back pain with o
60 s a major pathological process implicated in low back pain and is a prerequisite to disk herniation.
61 lly significant difference in improvement in low back pain and lower extremity pain between groups.
62 with betamethasone and triamcinolone reduced low back pain and lower extremity pain, although there w
65 anxiety, musculoskeletal disorders including low back pain and neck pain, diabetes, and cirrhosis--in
66 A 20-year-old man presented with 1 week of low back pain and progressive lower extremity weakness.
67 ic images, intracranial pressure processing, low back pain and real-time tumour tracking; (3) outcome
68 in intensity and disability in patients with low back pain and sciatica after lumbar disc herniation.
69 nce (MR) imaging in patients with persistent low back pain and sciatica effectively demonstrates spin
70 ans should evaluate patients with persistent low back pain and signs or symptoms of radiculopathy or
71 on (SOE, moderate) are effective for chronic low back pain and strengthens previous findings regardin
72 the most important factor leading to chronic low back pain and subsequent disability after discectomy
73 s important to remember about rare causes of low back pain and to perform detailed physical examinati
77 harmacologic therapies for primarily chronic low back pain are associated with small to moderate, usu
78 of moderate efficacy for chronic or subacute low back pain are cognitive-behavioral therapy, exercise
79 ood evidence of short-term effectiveness for low back pain are NSAIDs, acetaminophen, skeletal muscle
81 s for plain radiographs in the evaluation of low back pain are too sensitive and expose patients unne
83 ent state of managing chronic (and subacute) low back pain as reflected in recently published guideli
86 clinically important improvement in chronic low back pain compared with a standardized exercise prog
89 342 adults aged 20 to 70 years with chronic low back pain enrolled between September 2012 and April
90 s approximately 1.5), and a history of prior low back pain episodes and demographic variables were no
91 lated for prediction of persistent disabling low back pain for findings attainable during the clinica
92 thritis (OA), rheumatoid arthritis (RA), and low back pain from 12 community pharmacy sites responded
94 udies of patients with fewer than 8 weeks of low back pain from which likelihood ratios (LRs) were ca
96 en that most patients with acute or subacute low back pain improve over time regardless of treatment,
98 al cost of diagnostic imaging for persistent low back pain in 1990 relative to 1987 was estimated at
99 al cost of diagnostic imaging for persistent low back pain in 1990 relative to 1987 was estimated.
104 Higher BMI was significantly associated with low back pain in males (for overweight, odds ratio = 1.0
109 carpal tunnel syndrome, 59 million have had low back pain in the past 3 months, and 30.1 million hav
110 ith DZ twins, equating to a heritability for low back pain in the range of 52-68% and for neck pain i
113 ical examination to help place patients with low back pain into 1 of 3 broad categories: nonspecific
124 program to adults with chronic or recurrent low back pain led to greater improvements in back functi
128 ostic imaging is indicated for patients with low back pain only if they have severe progressive neuro
130 es, women were 1.5 times more likely to have low back pain or symptoms of intervertebral disc herniat
131 clinical trials of participants with chronic low back pain originating in the facet joints, sacroilia
134 ated to a person's health status) indicating low back pain severity were divided according to symptom
136 atory drugs had smaller benefits for chronic low back pain than previously observed, duloxetine was e
137 endorse triage to identify the rare cases of low back pain that are caused by medically serious patho
138 ive inception cohorts of patients with acute low back pain that measured fear of pain (often describe
140 e preceding medications for acute or chronic low back pain that reported pain outcomes, back-specific
141 The proportion of visits to specialists for low back pain that were new consultations increased from
142 studies varied from a low of 31% (n = 8) for low back pain to a high of 68% (n = 23) for fibromyalgia
143 e authors randomly selected 62 patients with low back pain to undergo either rapid MR imaging or plai
144 idemiologic studies report the prevalence of low back pain to vary from 7.6% to 37% in different popu
145 ic reviews and RCTs, for RCTs of adults with low back pain treated in ambulatory settings with SMT co
146 ard deviation]; age range, 20-79 years) with low back pain underwent standard 1.5-T MR imaging, which
149 raphy by a sports medicine clinic because of low back pain were evaluated for the presence of asympto
150 mponents for predicting persistent disabling low back pain were maladaptive pain coping behaviors, no
151 nostic imaging and testing for patients with low back pain when severe or progressive neurologic defi
152 atment selection in patients with persistent low back pain who are suspected of having herniated nucl
153 Recommendation 3: In patients with chronic low back pain who have had an inadequate response to non
154 y with SPECT can help identify patients with low back pain who would benefit from facet joint injecti
155 ptoms of low back pain alone and symptoms of low back pain with objective corroborating findings.
157 patients with evidence-based information on low back pain with regard to their expected course, advi
158 eporting (OP-8) reduced MR imaging rates for low back pain without conservative therapy in either Med
159 ion of MR imaging examinations performed for low back pain without history of conservative therapy.
160 ed by local DRG inflammation (a rat model of low back pain) and by a peripheral paw inflammation mode
161 h as imaging for patients with uncomplicated low back pain) and using the results for public reportin
163 nophen, skeletal muscle relaxants (for acute low back pain), and tricyclic antidepressants (for chron
164 nophen, skeletal muscle relaxants (for acute low back pain), and tricyclic antidepressants (for chron
168 2013, and October 24, 2014, and had chronic low back pain, a positive diagnostic block at the facet
169 that acupuncture may be useful for headache, low back pain, alcohol dependence, and paralysis resulti
170 pain and disability in patients with chronic low back pain, although this difference became nonsignif
172 served, duloxetine was effective for chronic low back pain, and benzodiazepines were ineffective for
173 that acetaminophen is ineffective for acute low back pain, and duloxetine is associated with modest
174 for improving function and reducing chronic low back pain, and the benefits persisted for at least s
175 ack disorders, with a particular emphasis on low back pain, as this area has been most represented in
176 in into 1 of 3 broad categories: nonspecific low back pain, back pain potentially associated with rad
177 sis and assessment of disease progression in low back pain, brain tumours and primary epilepsy; (2) e
178 and height are linked to the pathogenesis of low back pain, but evidence-based confirmation is lackin
179 ion is a commonly used treatment for chronic low back pain, but high-quality evidence for its effecti
180 iscs has been linked with the development of low back pain, but little is known about factors affecti
181 Recommendation 2: For patients with chronic low back pain, clinicians and patients should initially
184 in health centres respiratory insufficiency, low back pain, degree of physical function, presence of
185 arious musculoskeletal conditions, including low back pain, despite little scientific support for the
187 aluated included reduction or elimination of low back pain, improvement in back-specific and overall
188 spinal manipulation; for chronic or subacute low back pain, intensive interdisciplinary rehabilitatio
189 niated disc (HD), one of the major causes of low back pain, is often resolved spontaneously without s
190 llitus, and chronic pain conditions (chronic low back pain, knee osteoarthritis, and fibromyalgia).
191 with the largest number of YLDs in 2010 were low back pain, major depressive disorder, other musculos
193 that acetaminophen was ineffective for acute low back pain, nonsteroidal anti-inflammatory drugs had
194 heumatoid arthritis, osteoarthritis, chronic low back pain, or ischemic heart disease since 1995.
195 logic therapy with proven benefits-for acute low back pain, spinal manipulation; for chronic or subac
197 fferent rheumatic conditions (eg, neck pain, low back pain, systemic lupus erythematosus, fibromyalgi
201 include intense vulvar and vaginal itching, low back pain, uterine cramps, fetal distress, and prete
202 ty-seven patients (23 men and 24 women) with low back pain, who were scheduled for facet joint inject
203 ive-month period because of an acute, severe low back pain, with sphincter dysfunction, partially res
204 cians and American Pain Society guideline on low back pain, would provide better care to patients, im
270 prevalence of back and/or neck pain was 31% (low back pain: 34 million, neck pain: 9 million, both ba
271 rm trials showing modest effects for chronic low back pain; trials were not designed to assess seriou
273 ry of any allergy were more likely to report low-back pain (odds ratio = 1.51; 95% confidence interva
274 ore likely to have both major depression and low-back pain (odds ratio = 3.03; 95% confidence interva
275 ity were half as likely to have work-related low-back pain (OR=0.50, 95% CI 0.26-0.96) and nurses rep
276 e-sacral articulation of young patients with low-back pain and a lumbosacral transitional vertebra.
277 e; age range, 6-19 y; mean age, 15.7 y) with low-back pain and a lumbosacral transitional vertebra.
279 maging on clinical outcomes in patients with low-back pain and no indication of serious underlying co
280 r imaging in patients with acute or subacute low-back pain and without features suggesting a serious
282 d effect on troublesome subacute and chronic low-back pain at a low cost to the health-care provider.
283 f different imaging methods, and duration of low-back pain did not affect the results, but analyses w
286 Subjects responded to questions regarding low-back pain in the past 12 months and history of asthm
289 adults with troublesome subacute or chronic low-back pain were recruited from 56 general practices a
290 s is known about the epidemiology of chronic low-back pain with no associated work disability or comp
292 egenerative disc disease often causes severe low-back pain, a public health problem with huge economi
296 aration of small molecules and proteins with low back pressure are demonstrated by high-performance l
297 ous properties of the monoliths lead to very low back pressures enabling the use of simple mechanical
298 Given their high efficiencies and relatively low back pressures, columns containing these particles w
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。